These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36245866)

  • 41. Impaired prefrontal activity to regulate the intrinsic motivation-action link in schizophrenia.
    Takeda K; Matsumoto M; Ogata Y; Maida K; Murakami H; Murayama K; Shimoji K; Hanakawa T; Matsumoto K; Nakagome K
    Neuroimage Clin; 2017; 16():32-42. PubMed ID: 29071207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations of the glycine cleavage system genes possibly affect the negative symptoms of schizophrenia through metabolomic profile changes.
    Yoshikawa A; Nishimura F; Inai A; Eriguchi Y; Nishioka M; Takaya A; Tochigi M; Kawamura Y; Umekage T; Kato K; Sasaki T; Ohashi Y; Iwamoto K; Kasai K; Kakiuchi C
    Psychiatry Clin Neurosci; 2018 Mar; 72(3):168-179. PubMed ID: 29232014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
    Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
    J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
    [No Abstract]   [Full Text] [Related]  

  • 44. Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia.
    Shan B; Chen T; Huang B; Liu Y; Chen J
    J Ethnopharmacol; 2021 Dec; 281():114545. PubMed ID: 34419610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls.
    Vignapiano A; Mucci A; Merlotti E; Giordano GM; Amodio A; Palumbo D; Galderisi S
    Clin EEG Neurosci; 2018 Jan; 49(1):46-54. PubMed ID: 29243531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes.
    Zhuo C; Tian H; Chen J; Li Q; Yang L; Zhang Q; Chen G; Cheng L; Zhou C; Song X
    Front Genet; 2022; 13():880027. PubMed ID: 36061201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LC/MS-Based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics.
    Khan I; Nam M; Kwon M; Seo SS; Jung S; Han JS; Hwang GS; Kim MK
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients.
    Santa Cruz EC; Zandonadi FDS; Fontes W; Sussulini A
    Biochim Biophys Acta Proteins Proteom; 2021 Aug; 1869(8):140657. PubMed ID: 33839315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
    Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
    Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
    Wang R; Kang H; Zhang X; Nie Q; Wang H; Wang C; Zhou S
    BMC Cancer; 2022 Feb; 22(1):214. PubMed ID: 35220945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurocognitive Endophenotypes of Schizophrenia and Bipolar Disorder and Possible Associations with FKBP Variant rs3800373.
    Memic A; Streit F; Hasandedic L; Witt SH; Strohmaier J; Rietschel M; Oruc L
    Med Arch; 2018 Nov; 72(5):352-356. PubMed ID: 30524168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between cognition and color discrimination among Lebanese patients with schizophrenia.
    Dahdouh O; Solh T; Lahoud C; Haddad C; Hallit S
    BMC Psychiatry; 2022 Sep; 22(1):606. PubMed ID: 36096757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of potential biomarkers in acute kidney injury by ultra-high-performance liquid chromatography-tandem quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS).
    Chen C; Zhang P; Bao G; Fang Y; Chen W
    Int Urol Nephrol; 2021 Dec; 53(12):2635-2643. PubMed ID: 33686532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Arachidonic Acid Metabolism Mechanism Based on UPLC-MS/MS Metabolomics in Recurrent Spontaneous Abortion Rats.
    Li M; Haixia Y; Kang M; An P; Wu X; Dang H; Xu X
    Front Endocrinol (Lausanne); 2021; 12():652807. PubMed ID: 33868179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A preliminary metabolomics study of the database for biological samples of schizophrenia among Chinese ethnic minorities.
    Ye J; Chen H; Wang Y; Chen H; Huang J; Yang Y; Feng Z; Li W
    BMC Psychiatry; 2024 Apr; 24(1):262. PubMed ID: 38594695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of simultaneous quantitative analysis of tricarboxylic acid cycle metabolites to identify specific metabolites in cancer cells by targeted metabolomic approach.
    Yamamoto T; Sato K; Yamaguchi M; Mitamura K; Taga A
    Biochem Biophys Res Commun; 2021 Dec; 584():53-59. PubMed ID: 34768082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
    Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
    J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery.
    Xia L; Yuan L; Du XD; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Trihn TH; Alnatour OI; Chen D; Xiu M; Wang L; Yang M; Zhang XY
    Schizophr Res; 2020 Jan; 215():105-112. PubMed ID: 31780341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteomic analysis of lymphoblastoid cell lines from schizophrenic patients.
    Yoshimi A; Yamada S; Kunimoto S; Aleksic B; Hirakawa A; Ohashi M; Matsumoto Y; Hada K; Itoh N; Arioka Y; Kimura H; Kushima I; Nakamura Y; Shiino T; Mori D; Tanaka S; Hamada S; Noda Y; Nagai T; Yamada K; Ozaki N
    Transl Psychiatry; 2019 Apr; 9(1):126. PubMed ID: 31011151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.